Involvement of the chemokine CCL3 and the purinoceptor P2X7 in the spinal cord in paclitaxel-induced mechanical allodynia

详细信息    查看全文

• 作者：Ryutaro Ochi-ishi (1)
  Kenichiro Nagata (1)
  Tomoyuki Inoue (1)
  Hidetoshi Tozaki-Saitoh (1)
  Makoto Tsuda (1)
  Kazuhide Inoue (1)
  
  1. Department of Molecular and System Pharmacology ; Graduate School of Pharmaceutical Sciences ; Kyushu University ; 3-1-1 MaidashiHigashi-ku ; Fukuoka ; 812-8582 ; Japan
  
• 关键词：Paclitaxel ; Microglia ; Chemokines ; Spinal cord ; Allodynia ; Rats
• 刊名：Molecular Pain
• 出版年：2014
• 出版时间：December 2014
• 年：2014
• 卷：10
• 期：1
• 全文大小：531 KB
• 参考文献：1. Scripture, CD, Figg, WD, Sparreboom, A (2006) Peripheral neuropathy induced by paclitaxel: recent insights and future perspectives. Curr Neuropharmacol 4: pp. 165-172 CrossRef
  2. Argyriou, AA, Koltzenburg, M, Polychronopoulos, P, Papapetropoulos, S, Kalofonos, HP (2008) Peripheral nerve damage associated with administration of taxanes in patients with cancer. Crit Rev Oncol Hematol 66: pp. 218-228 CrossRef
  3. Tanabe, Y, Hashimoto, K, Shimizu, C, Hirakawa, A, Harano, K, Yunokawa, M, Yonemori, K, Katsumata, N, Tamura, K, Ando, M, Kinoshita, T, Fujiwara, Y (2013) Paclitaxel-induced peripheral neuropathy in patients receiving adjuvant chemotherapy for breast cancer. Int J Clin Oncol 18: pp. 132-138 CrossRef
  4. Scholz, J, Woolf, CJ (2007) The neuropathic pain triad: neurons, immune cells and glia. Nat Neurosci 10: pp. 1361-1368 CrossRef
  5. Inoue, K, Tsuda, M (2009) Microglia and neuropathic pain. Glia 57: pp. 1469-1479 CrossRef
  6. Tsuda, M, Masuda, T, Tozaki-Saitoh, H, Inoue, K (2013) P2X4 receptors and neuropathic pain. Front Cell Neurosci 7: pp. 191 CrossRef
  7. White, FA, Jung, H, Miller, RJ (2007) Chemokines and the pathophysiology of neuropathic pain. Proc Natl Acad Sci U S A 104: pp. 20151-20158 CrossRef
  8. Kuner, R (2010) Central mechanisms of pathological pain. Nat Med 16: pp. 1258-1266 CrossRef
  9. Peters, CM, Jimenez-Andrade, JM, Jonas, BM, Sevcik, MA, Koewler, NJ, Ghilardi, JR, Wong, GY, Mantyh, PW (2007) Intravenous paclitaxel administration in the rat induces a peripheral sensory neuropathy characterized by macrophage infiltration and injury to sensory neurons and their supporting cells. Exp Neurol 203: pp. 42-54 CrossRef
  10. Cata, JP, Weng, HR, Dougherty, PM (2008) The effects of thalidomide and minocycline on taxol-induced hyperalgesia in rats. Brain Res 1229: pp. 100-110 CrossRef
  11. Kataoka, A, Tozaki-Saitoh, H, Koga, Y, Tsuda, M, Inoue, K (2009) Activation of P2X7 receptors induces CCL3 production in microglial cells through transcription factor NFAT. J Neurochem 108: pp. 115-125 CrossRef
  12. Matsushita, K, Tozaki-Saitoh, H, Kojima, C, Masuda, T, Tsuda, M, Inoue, K, Hoka, S (2014) Chemokine (C-C motif) receptor 5 is an important pathological regulator in the development and maintenance of neuropathic pain. Anesthesiology 120: pp. 1491-1503 CrossRef
  13. Kiguchi, N, Kobayashi, Y, Maeda, T, Saika, F, Kishioka, S (2010) CC-chemokine MIP-1alpha in the spinal cord contributes to nerve injury-induced neuropathic pain. Neurosci Lett 484: pp. 17-21 CrossRef
  14. Maurer, M, von Stebut, E (2004) Macrophage inflammatory protein-1. Int J Biochem Cell Biol 36: pp. 1882-1886 CrossRef
  15. Padi, SS, Shi, XQ, Zhao, YQ, Ruff, MR, Baichoo, N, Pert, CB, Zhang, J (2012) Attenuation of rodent neuropathic pain by an orally active peptide, RAP-103, which potently blocks CCR2- and CCR5-mediated monocyte chemotaxis and inflammation. Pain 153: pp. 95-106 CrossRef
  16. Chaplan, SR, Bach, FW, Pogrel, JW, Chung, JM, Yaksh, TL (1994) Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 53: pp. 55-63 CrossRef
  17. McGaraughty, S, Chu, KL, Namovic, MT, Donnelly-Roberts, DL, Harris, RR, Zhang, XF, Shieh, CC, Wismer, CT, Zhu, CZ, Gauvin, DM, Fabiyi, AC, Honore, P, Gregg, RJ, Kort, ME, Nelson, DW, Carroll, WA, Marsh, K, Faltynek, CR, Jarvis, MF (2007) P2X7-related modulation of pathological nociception in rats. Neuroscience 146: pp. 1817-1828 CrossRef
  18. Abbracchio, MP, Burnstock, G, Verkhratsky, A, Zimmermann, H (2009) Purinergic signalling in the nervous system: an overview. Trends Neurosci 32: pp. 19-29 CrossRef
  19. Okamura, T, Katayama, T, Obinata, C, Iso, Y, Chiba, Y, Kobayashi, H, Yamada, Y, Harashima, H, Minami, M (2012) Neuronal injury induces microglial production of macrophage inflammatory protein-1alpha in rat corticostriatal slice cultures. J Neurosci Res 90: pp. 2127-2133 CrossRef
  20. Kobayashi, K, Takahashi, E, Miyagawa, Y, Yamanaka, H, Noguchi, K (2011) Induction of the P2X7 receptor in spinal microglia in a neuropathic pain model. Neurosci Lett 504: pp. 57-61 CrossRef
  21. He, WJ, Cui, J, Du, L, Zhao, YD, Burnstock, G, Zhou, HD, Ruan, HZ (2012) Spinal P2X(7) receptor mediates microglia activation-induced neuropathic pain in the sciatic nerve injury rat model. Behav Brain Res 226: pp. 163-170 CrossRef
  22. Kim, B, Jeong, HK, Kim, JH, Lee, SY, Jou, I, Joe, EH (2011) Uridine 5'-diphosphate induces chemokine expression in microglia and astrocytes through activation of the P2Y6 receptor. J Immunol 186: pp. 3701-3709 CrossRef
  23. Yoon, SY, Robinson, CR, Zhang, H, Dougherty, PM (2013) Spinal astrocyte gap junctions contribute to oxaliplatin-induced mechanical hypersensitivity. J Pain 14: pp. 205-214 CrossRef
  24. Ji, XT, Qian, NS, Zhang, T, Li, JM, Li, XK, Wang, P, Zhao, DS, Huang, G, Zhang, L, Fei, Z, Jia, D, Niu, L (2013) Spinal astrocytic activation contributes to mechanical allodynia in a rat chemotherapy-induced neuropathic pain model. PLoS One 8: pp. e60733 CrossRef
  25. Kiguchi, N, Maeda, T, Kobayashi, Y, Fukazawa, Y, Kishioka, S (2010) Macrophage inflammatory protein-1alpha mediates the development of neuropathic pain following peripheral nerve injury through interleukin-1beta up-regulation. Pain 149: pp. 305-315 CrossRef
  26. Gamo, K, Kiryu-Seo, S, Konishi, H, Aoki, S, Matsushima, K, Wada, K, Kiyama, H (2008) G-protein-coupled receptor screen reveals a role for chemokine receptor CCR5 in suppressing microglial neurotoxicity. J Neurosci 28: pp. 11980-11988 CrossRef
  27. Jo, YH, Schlichter, R (1999) Synaptic corelease of ATP and GABA in cultured spinal neurons. Nat Neurosci 2: pp. 241-245 CrossRef
  28. Fam, SR, Gallagher, CJ, Salter, MW (2000) P2Y(1) purinoceptor-mediated Ca(2+) signaling and Ca2+ wave propagation in dorsal spinal cord astrocytes. J Neurosci 20: pp. 2800-2808
  29. Pevida, M, Lastra, A, Hidalgo, A, Baamonde, A, Menendez, L (2013) Spinal CCL2 and microglial activation are involved in paclitaxel-evoked cold hyperalgesia. Brain Res Bull 95: pp. 21-27 CrossRef
  
• 刊物主题：Pain Medicine; Molecular Medicine;
• 出版者：BioMed Central
• ISSN：1744-8069

文摘

Background Paclitaxel is an effective chemotherapeutic agent widely used for the treatment of solid tumors. The major dose-limiting toxicity of paclitaxel is peripheral neuropathy. The mechanisms underlying the development and maintenance of paclitaxel-induced peripheral neuropathy are still unclear, and there are no currently established effective treatments. Accumulating evidence in models of neuropathic pain in which peripheral nerves are lesioned has implicated spinal microglia and chemokines in pain hypersensitivity, but little is know about their roles in chemotherapy-induced peripheral neuropathy. In the present study, we investigated the role of CC-chemokine ligand 3 (CCL3) in the spinal cord in the development and maintenance of mechanical allodynia using a rat model of paclitaxel-induced neuropathy. Findings Repeated intravenous administration of paclitaxel induced a marked decrease in paw withdrawal threshold in response to mechanical stimulation (mechanical allodynia). In these rats, the number of microglia in the spinal dorsal horn (SDH) was significantly increased. Paclitaxel-treated rats showed a significant increase in the expression of mRNAs for CCL3 and its receptor CCR5 in the SDH. Intrathecal administration of a CCL3-neutralizing antibody not only attenuated the development of paclitaxel-induced mechanical allodynia but also reversed its maintenance. Paclitaxel also upregulated expression of purinoceptor P2X7 receptors (P2X7Rs), which have been implicated in the release of CCL3 from microglia, in the SDH. The selective P2X7R antagonist A438079 had preventive and reversal effects on paclitaxel-induced allodynia. Conclusions Our findings suggest a contribution of CCL3 and P2X7Rs in the SDH to paclitaxel-induced allodynia and may provide new therapeutic targets for paclitaxel-induced painful neuropathy.